Save Comparison | ![]() Osmotica Pharmaceuticals Osmotica Pharmaceutical is a fully-integrated pharmaceutical company specializing in osmotic drug delivery. | ![]() Opiant Pharmaceuticals Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders. | ![]() Adamas Pharmaceuticals Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders. | ![]() IntelGenx IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. | ![]() Generex Biotechnology Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases. |
Founding Date | Founding Date 2000 | Founding Date 2009 | Founding Date 2002 | Founding Date 2003 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Bridgewater, US HQ Almagro, AR Budapest, HU North Wall, IE Marietta, US Sayreville, US Tampa, US see more | Locations Santa Monica, US HQ London, GB Santa Monica, US | Locations Emeryville, US HQ | Locations Saint-Laurent, CA HQ | Locations Burlington, CA HQ Miramar, US |
Employees | Employees 46613% increase | Employees 2131% increase | Employees 1361% increase | Employees 4826% increase | Employees 9200% increase |
Valuation ($) | Valuation ($) 288.5 m | Valuation ($) 46.1 m | Valuation ($) 158 m | Valuation ($) 27.6 m | Valuation ($) 46.7 m |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers N/A | Twitter followers 1.1 k | Twitter followers 770 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 6 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3 | Average likes per tweet (last 30 days) 6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 277297 | Alexa Website Rank 331763 | Alexa Website Rank 150475 | Alexa Website Rank 356125 | Alexa Website Rank 358312 |
Employee Rating | Employee Rating 2.6 | Employee Rating N/A | Employee Rating 3.8 | Employee Rating 3.4 | Employee Rating 3 |
Financial | |||||
Revenue (est.) | Revenue (est.) $240m (FY, 2019) | Revenue (est.) $40.5m (FY, 2019) | Revenue (est.) $54.6m (FY, 2019) | Revenue (est.) $742k (FY, 2019) | Revenue (est.) $6.2m (FY, 2019) |
Cost of goods | Cost of goods $111.6m (FY, 2019) | Cost of goods N/A | Cost of goods $2.5m (FY, 2019) | Cost of goods N/A | Cost of goods $4.1m (FY, 2019) |
Gross profit | Gross profit $128.4m (FY, 2019) | Gross profit $40.5m (FY, 2019) | Gross profit $52.2m (FY, 2019) | Gross profit N/A | Gross profit $2.1m (FY, 2019) |
Net income | Net income ($270.9m) (FY, 2019) | Net income $11.6m (FY, 2019) | Net income ($105.2m) (FY, 2019) | Net income ($10.7m) (FY, 2019) | Net income ($11m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 82m | Total funding raised $ 1.7m | Total funding raised N/A |
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
View companyAdamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
View companyIntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
View companyGenerex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
View company